Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration.
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000937:Antigen-Antibody Reactions; D001219:Aspartate Aminotransferases / Q000097:blood; D001650:Bile Duct Neoplasms / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001786:Blood Glucose / Q000032:analysis; D002404:Catheterization; D002764:Cholecystitis / Q000097:blood; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood*; D007330:Insulin Antibodies; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000097:blood / Q000473:pathology; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000097:blood; D010437:Peptic Ulcer / Q000097:blood; D011169:Portal Vein; D014044:Tolbutamide / Q000008:administration & dosage*; D014471:Umbilical Veins; D014680:Veins
D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies; D014044:Tolbutamide; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin